[1]李铭轩,肖晓燕,原 彰.中国归因于高BMI的高血压性心脏病疾病负担研究[J].卫生经济研究,2025,42(11):38-44.
 LI Mingxuan,XIAO Xiaoyan,YUAN Zhang.Study on the Disease Burden of Hypertensive Heart Disease Attributable to High BMI in China[J].Journal Press of Health Economics Research,2025,42(11):38-44.
点击复制

中国归因于高BMI的高血压性心脏病疾病负担研究

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
42
期数:
2025年11期
页码:
38-44
栏目:
成本与费用
出版日期:
2025-11-04

文章信息/Info

Title:
Study on the Disease Burden of Hypertensive Heart Disease Attributable to High BMI in China
作者:
李铭轩1肖晓燕1原 彰23
1.广州中医药大学护理学院,广东 广州 510006
2.广州中医药大学公共卫生与管理学院,广东 广州 510006
3.广东省中医药健康服务与产业发展研究中心,广东 广州 510006
Author(s):
LI Mingxuan XIAO Xiaoyan YUAN Zhang
School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou Guangdong 510006, China
关键词:
高BMI高血压性心脏病疾病负担
Keywords:
high BMI hypertensive heart disease disease burden
分类号:
R19
文献标志码:
A
摘要:
目的:对1990—2021年中国归因于BMI的高血压性心脏病疾病负担进行分析,并预测未来变化趋势。方法:利用全球疾病负担数据库,选取1990—2021年中国归因于高BMI的高血压性心脏病疾病负担相关指标进行分析及预测。结果:1990—2021年,中国归因于高BMI的高血压性心脏病死亡率、标化死亡率、DALY率及标化DALY率均呈现先降后升的趋势,虽然2021年标化死亡率(6.90/10万)和标化DALY率(120.03/10万)均低于全球平均水平(7.21/10万、147.33/10万),但未来10年死亡率和DALY率将呈逐年上升趋势,死亡率预计会上升至12.05/10万,DALY率预计会上升至222.37/10万。结论:中国归因于高BMI的高血压性心脏病疾病负担较重,应把握“体重管理年”契机,及时采取应对措施,加强对重点人群的干预,有效减轻高BMI导致的高血压性心脏病疾病负担。
Abstract:
Objective To analyze the disease burden of hypertensive heart disease attributable to BMI in China from 1990 to 2021, and to predict future trends. Methods Using the Global Burden of Disease database, the indicators related to the burden of hypertensive heart disease attributable to high BMI in China from 1990 to 2021 were analyzed and projected. Results From 1990 to 2021, the mortality rate, standardized mortality rate, DALY rate, and standardized DALY rate of hypertensive heart disease attributable to high BMI in China all showed a trend of initial decline followed by increase. Although the standardized mortality rate(6.90 per 100 000) and standardized DALY rate (120.03 per 100 000) in 2021 were below global averages (7.21 per 100 000 and 147.33 per 100 000, respectively), both metrics would increase annually over the next decade. The mortality rate was expected to rise to 12.05 per 100 000, and the DALY rate was projected to rise to 222.37 per 100 000. Conclusion The disease burden of hypertensive heart disease attributable to high BMI in China is relatively heavy. It is necessary to seize the opportunity presented by the "Weight Management Year" initiative, timely implement the countermeasures, and strengthen the interventions for key populations, so as to effectively reduce the disease burden of hypertensive heart disease caused by high BMI.

参考文献/References:

[1] 中国营养学会肥胖防控分会,西安交通大学全球健康研究院,国际肥胖与代谢性疾病研究中心,等.2025年世界肥胖报告[J].西安交通大学学报(医学版),2025,46(02):363-379.
[2] GBD 2021 Risk Factors Collaborators.Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2162-2203.
[3] Zhou XD,Chen QF,Yang W,et al.Burden of disease attributable to high body mass index:an analysis of data from the Global Burden of Disease Study 2021[J].E Clinical Medicine,2024,24(76):102848.
[4] 向晓睿,赵世华.高血压性心脏病磁共振成像现状与进展[J].中国循环杂志,2022,37(10):1069-1072.
[5] Qiao W,Zhang X,Kan B,et al.Hypertension,BMI,and cardiovascular and cerebrovascular diseases[J].Open Med(Wars),2021,16(01):149-155.
[6] Hu B,Shi Y,Zhang P,et al.Global,regional,and national burdens of hypertensive heart disease from 1990 to 2019:a multilevel analysis based on the global burden of disease study 2019[J].Heliyon,2023,9(12):e22671.
[7] GBD 2021 Risk Factors Collaborators.Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet,2024,403(10440):2162-2203.
[8] GBD 2019 Risk Factors Collaborators.Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1223-1249.
[9] GBD Healthcare Access and Quality Collaborators.Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations:a systematic analysis from the Global Burden of Disease Study 2016[J]. Lancet,2018,391(10136):2236-2271.
[10] Tichenor M.Sridhar D.Metric partnerships:global burden of disease estimates within the World Bank,the World Health Organisation and the Institute for Health Metrics and Evaluation[J].Wellcome Open Res,2020(04):35.
[11] Lee M,Lakshminarayan K,Sedaghat S,et al.Population attributable fraction of total stroke associated with modifiable risk factors in the United States[J].Am J Epidemiol,2024,193(12):1712-1719.
[12] Malenfant,Jason H,John A Batsis.Obesity in the geriatric population-a global health perspective[J].Journal of Global Health Reports,2019(03):e2019045.
[13] 魏潇琪,琚腊红,于冬梅,等.中国2002—2015年≥18岁成人在外就餐行为变化趋势及其对肥胖影响[J].中国公共卫生,2022,38(05):570-576.
[14] 梁盛兴,邹俐爱,邱恒,等.1990—2021年中国归因于高BMI的慢性肾病疾病负担研究[J].卫生经济研究,2025,42(04):42-46,52.
[15] Du Y,Rong S, Sun Y,et al.Association between frequency of eating away-from-home meals and risk of all-cause and cause-specific mortality[J].Journal of the Academy of Nutrition and Dietetics vol,2021,121(09):1741-1749.
[16] Wang L,Zhou B,Zhao Z,et al.Body-mass index and obesity in urban and rural China:findings from consecutive nationally representative surveys during 2004-18[J].Lancet,2021,398(10294):53-63.
[17] 许晓丽,王惠君,房红芸,等.2002—2015年中国成年人饮酒状况变迁[J].卫生研究,2025,54(02):201-207,221.
[18] Fang Y,Xia J,Lian Y,et al.The burden of cardiovascular disease attributable to dietary risk factors in the provinces of China,2002—2018:a nationwide population-based study[J].Lancet Reg Health West Pac,2023,37:100784.
[19] 李瑶玥,王桂新.社会经济因素对中国居民肥胖的影响[J].人口与发展,2022,28(05):107-125.
[20] 吴菲.社会决定抑或身材筛选?社会经济地位与肥胖的性别化因果关系[J].社会,2021,41(02):218-242.
[21] 魏嘉畅,刘姿琪, 孙嘉鸿,等.中国中老年人群体力活动量与全因死亡风险关系及其中介因子分析[J].中国公共卫生,2024,40(06):730-736.
[22] 陆杰华,林嘉琪.重度老龄化社会的人口特征、风险识别与战略应对[J].中国特色社会主义研究,2023(01):59-68. [23] 汤美慧,田姝菀,谢天.超越瘦身迷思:“以瘦为美”的社会规范对青年群体积极身体意象与热量摄入的影响[J].心理学报,2024,56(10):1367-1383. [24] Liao Y,Gilmour S,Shibuya K.Health insurance coverage and hypertension control in China:results from the China health and nutrition survey[J].PloS One,2016,11(03):e0152091. [25] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压病学分会,等.中国高血压防治指南(2024年修订版)[J].中华高血压杂志(中英文),2024,32(07):603-700. [26] 房红芸,魏潇琪,琚腊红,等.1982—2015年中国成年居民体质指数现状及变化趋势[J].卫生研究,2025,54(01):18-22. [27] 彭希哲,周祥.中国人口发展与老龄化应对[J].新金融,2024(04):8-13. [28] 王蕊琪,周郁秋,贾红红.慢性病患者就医行为影响因素研究进展[J].护理学报,2018,25(03):24-28. [29] 高敏,李晓娜,时永利,等.老年慢性病患者用药体验对用药依从性的影响研究[J].中国全科医学,2025,28(11):1309-1314.

更新日期/Last Update: 2025-11-04